ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2108

DNA Hypomethylation in Promoter Region of Zbtb38 Gene Ultimately Leads to Downregulated Expression of Anti-Inflammatory IL1r2 in Experiential Model of Rheumatoid Arthritis

Timea Ocskó1, Daniel M. Tóth1, Attila Balog2, Katalin Mikecz1, Tibor T. Glant1 and Tibor A. Rauch3, 1Orthopedic Surgery, Rush University Medical Center, Chicago, IL, 2Rheumatology, Albert Szent-Gyorgyi University, Szeged, Hungary, 31735 W. Harrison Str., Rush University Medical Center, Chicago, IL

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Animal models, DNA Methylation, epigenetics and rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: B Cell Biology and Targets in Autoimmune Disease - Poster II: Rheumatoid Arthritis and Other Rheumatic Diseases

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Interleukin 1 beta (IL1B) is a multifunctional cytokine that is highly expressed in rheumatoid arthritis (RA) and drives pro-inflammatory pathways via interleukin 1 receptor 1 (IL1R1)-mediated signaling. IL1B-specific receptor, IL1r2 is a decoy receptor that can sequester IL1B and acts as an anti-inflammatory factor. We investigated how an arthritis-specific epigenetic event is connected with the suppressed expression of anti-inflammatory IL1r2. The main goal of the current study is to explore gene regulatory pathways are involved in arthritis.

Methods: Disease-associated DNA methylation profiles analyses were conducted by methylated CpG island recovery assay (MIRA-chip) in arthritic B cells. Gene expression changes were investigated by microarray platforms and quantitative real-time polymerase chain reaction (RT-qPCR). Targeted gene silencing was carried out by electroporation of gene-specific shRNA expressing plasmids, and gene expression changes were monitored using RT–qPCR and Western blotting. Transient transfection studies were used for functional characterization of IL1r2 promoter.

Results: The promoter region of Zbtb38 transcription factor encoding gene was differentially methylated in B cells isolated from arthritic mice, which hypomethylation resulted in high expression of Zbtb38. Zbtb38 directly regulates IL1r2 gene expression and initiates its silencing in arthritic B cells. AhR transcription factor is also intimately involved in transcriptional regulation of IL1r2 and acts against Zbtb38. The fine balance of these two transcription factors can define the actual expression status of IL1r2 gene.

Conclusion: Zbtb38 forms a molecular bridge between an arthritis-associated epigenetic alteration (i.e., de novo DNA hypomethylation in Zbtb38 promoter) and transcriptional silencing of IL1r2 gene in arthritic B cells. In this context, Zbtb38 works as a potent repressor that turns off an anti-inflammatory pathway and significantly contributes to pathogenesis of arthritis.


Disclosure: T. Ocskó, None; D. M. Tóth, None; A. Balog, None; K. Mikecz, None; T. T. Glant, None; T. A. Rauch, None.

To cite this abstract in AMA style:

Ocskó T, Tóth DM, Balog A, Mikecz K, Glant TT, Rauch TA. DNA Hypomethylation in Promoter Region of Zbtb38 Gene Ultimately Leads to Downregulated Expression of Anti-Inflammatory IL1r2 in Experiential Model of Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/dna-hypomethylation-in-promoter-region-of-zbtb38-gene-ultimately-leads-to-downregulated-expression-of-anti-inflammatory-il1r2-in-experiential-model-of-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dna-hypomethylation-in-promoter-region-of-zbtb38-gene-ultimately-leads-to-downregulated-expression-of-anti-inflammatory-il1r2-in-experiential-model-of-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology